Delcher Chris, Wang Yanning, Young Henry W, Goldberger Bruce A, Schmidt Siegfried, Reisfield Gary M
Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, Florida.
Data Management Analyst, Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, Florida.
J Opioid Manag. 2017 Sep/Oct;13(5):283-289. doi: 10.5055/jom.2017.0397.
Effective use of state prescription drug monitoring programs (PDMPs) to track controlled substance prescribing and dispensing may help mitigate the current opioid crisis. Our objective was to examine trends in registration for and use of Florida's PDMP by physicians and pharmacists, from 2013 to 2016. We discuss implications for PDMP uptake and policy.
Key measures, such as cumulative number of registrants per license type and monthly utilization intensity, are presented. A time series forecasting approach was used to (1) model the monthly count of new PDMP registrants and users from January 2013 to December 2016 and (2) estimate cumulative registration totals after 1 year.
Florida.
As of November 2016, there were 16,498 physicians (representing 31 percent of Drug Enforcement Administration licensees) and 17,241 pharmacists registered with the PDMP, representing 21 and 57 percent of professional licensees, respectively. Of note, the PDMP's designation as a "specialized registry" for electronic medical record "meaningful use" criteria led to a nearly sevenfold increase in physician registrations in a single month. In November 2016, pharmacists displayed a higher past-month PDMP utilization rate (52.2 percent vs 30.1 percent), while physicians displayed a higher past-month PDMP utilization intensity (58.1 vs. 36.1 queries per user). Approximately 25,000 physicians and 31,000 pharmacists must register by the end of 2017 to meet national policy goals.
PDMP registration among physicians and pharmacists is limited, and the use of the PDMP among registrants is more limited still. Our findings suggest that Florida will not meet national policy goals for registrants by the end of 2017, although new initiatives may alter this trend. Allowing the PDMP to help prescribers meet other professional needs, such as "meaningful use" or similar efforts, may be effective in increasing PDMP use.
有效利用州处方药监测计划（PDMPs）来追踪管制药品的开处方和配药情况，可能有助于缓解当前的阿片类药物危机。我们的目的是研究2013年至2016年佛罗里达州医生和药剂师注册及使用该州PDMP的趋势。我们讨论了对PDMP采用情况和政策的影响。
列出了关键指标，如每种许可证类型的累计注册人数和每月使用强度。采用时间序列预测方法来（1）对2013年1月至2016年12月新的PDMP注册者和使用者的月度计数进行建模，以及（2）估计1年后的累计注册总数。
佛罗里达州。
截至2016年11月，有16498名医生（占缉毒局持证人的31%）和17241名药剂师在PDMP注册，分别占专业持证人的21%和57%。值得注意的是，PDMP被指定为电子病历“有意义使用”标准的“专门登记处”，导致医生注册人数在一个月内增加了近7倍。2016年11月，药剂师上个月的PDMP使用率较高（52.2%对30.1%），而医生上个月的PDMP使用强度较高（每位用户58.1次查询对36.1次查询）。到2017年底，约2500名医生和31000名药剂师必须注册，才能实现国家政策目标。
医生和药剂师中PDMP的注册人数有限，注册者中对PDMP的使用更为有限。我们的研究结果表明，尽管新举措可能会改变这一趋势，但佛罗里达州到2017年底仍无法实现国家注册者政策目标。允许PDMP帮助开处方者满足其他专业需求，如“有意义使用”或类似举措，可能会有效增加PDMP的使用。
